EE550 Cost-Effectiveness Analysis of Brentuximab Vedotin in Combination With Doxorubicin, Vinblastine and Dacarbazine (AVD) in Newly Diagnosed Stage III Hodgkin Lymphoma in Italy
Abstract
Authors
A Marcellusi C Bini S Ripoli L Fioravanti A Molinari P Morelli M Krotneva S Li V Paly